Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext

Sanjay Basu talks with The Lancet Diabetes &amp; Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries. Read the full article: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext

Sanjay Basu on affordable T2D medicine in LMICs

Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Share Sanjay Basu on affordable T2D medicine in LMICs

Sign up to save your podcasts

Sanjay Basu on affordable T2D medicine in LMICs

Sanjay Basu on affordable T2D medicine in LMICs